Cargando…
LOVIT or leave it: The vitamin C debate continues
Autores principales: | Lankadeva, Yugeesh R., Lane, Darius JR., Ow, Connie PC., Story, David A., Plummer, Mark P., May, Clive N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10581254/ https://www.ncbi.nlm.nih.gov/pubmed/37876602 http://dx.doi.org/10.1016/j.ccrj.2023.05.001 |
Ejemplares similares
-
Mega-dose sodium ascorbate: a pilot, single-dose, physiological effect, double-blind, randomized, controlled trial
por: Yanase, Fumitaka, et al.
Publicado: (2023) -
Targeting Oxidative Stress in Septic Acute Kidney Injury: From Theory to Practice
por: Ow, Connie P. C., et al.
Publicado: (2021) -
Lessening Organ Dysfunction With Vitamin C (LOVIT) Trial: Statistical Analysis Plan
por: Adhikari, Neill KJ, et al.
Publicado: (2022) -
Intravenous vitamin C in adults with sepsis in the intensive care unit: still LOV’IT?
por: Stoppe, Christian, et al.
Publicado: (2022) -
Lessening Organ dysfunction with VITamin C (LOVIT): protocol for a randomized controlled trial
por: Masse, Marie-Hélène, et al.
Publicado: (2020)